Bushu Pharmaceuticals, Ltd. (Head Office: Kawagoe-city, Saitama Prefecture, Japan; hereinafter “Bushu”) is pleased to announce that on March 31, 2014, it completed the transfer of business operations of Eisai Misato Plant (location: Saitama Prefecture, Japan), one of manufacturing facilities of Eisai Co., Ltd. (Head Office: Tokyo, Japan; hereinafter “Eisai”), which was announced in Bushu’s news release titled “Execution of Business Transfer Agreement with Eisai Co., Ltd. for the acquisition of business operations of Eisai Misato Plant” dated November 29, 2013. Misato Plant, a new manufacturing powerhouse of Bushu, commenced its operations today.

With the acquisition of Misato Plant, Bushu has started a new fiscal year with a two-plant structure with its existing Kawagoe Plant. Together with Misato Plant, Bushu will be able to significantly boost its production capacity of solid formulations from the current approx. 3.5 billion to approx. 10 billion tablets, which will further enhance not only Bushu’s reliability of pharmaceutical supply but also its business stability and expandability. The combined production force of the two plants will further enhance Bushu’s R&D capabilities and accelerate its growth strategies to become a Contract Development and Manufacturing Organization (CDMO). Furthermore, with the acquisition of filling lines for injectable in Misato Plant, Bushu will be able to provide one-stop services for the entire continuum of pharmaceutical production process from solid to injectable dosage form, and as a comprehensive CDMO, it will be able to further secure new customers and to expand the business. Bushu, established as an independent contract manufacturing organization for pharmaceutical products and clinical trial materials, strongly believes that the acquisition of Misato Plant will dramatically strengthen its operating base.

Bushu intends to continue to emphasize the manufacturing of pharmaceutical products as a pioneer of global contract manufacturing organization, and, as a company with a high raison d’être depended on by customers all around the world, Bushu shall work to ensure it always remains the number one choice.

About Bushu Pharmaceuticals, Ltd.

Bushu Pharmaceuticals Ltd. was established in August 1998 as an independent pharmaceutical contract manufacturer. Bushu has a capital of 1 billion yen.

Contact Details

Bushu Pharmaceuticals Ltd.
Contact Information: Hirofumi Takeuchi
Operating Officer & Division Manager
Administration Division Phone: +81-(0)49-233-4651

News + PR

Related File

• press_release_14_4-1_eng.pdf